Mablink Bioscience
ID: 7647767Mablink Bioscience is an antibody-drug Conjugates founded in 2018.
3
Funding Rounds
$39.6m
Money raised
Recent Funding Rounds
Overview
Mablink Bioscience is an antibody-drug Conjugates founded in 2018.
- Website:
- Business model: B2B
- Headquarters: Lyon
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Mablink Bioscience has raised a total of $39.6m in funding over 3 rounds.
Key Insights:
- Mablink Bioscience October 2022 Series A Funding Round: $30m
- Mablink Bioscience Seed round, April 2021: $4.8m
- Mablink Bioscience April 2021 Seed Funding Round: $4.8m
Industries
Mablink Bioscience is active in the following industries: